Group 1 - Fulin Precision's subsidiary plans to invest 6 billion yuan to build a high-end lithium iron phosphate project with an annual production capacity of 500,000 tons [11] - Feiwo Technology has completed the acquisition of 60% of Xinsai Aerospace, focusing on metal 3D printing services for commercial aerospace [2] - Zhongcai Technology expects a net profit increase of 73.79% to 118.64% in 2025 [30] Group 2 - Hengrui Medicine has received approval for clinical trials of HRS9531 injection in combination with HRS-5817 injection for treating obesity [2] - Deyun Co. announced that its actual controller has been arrested for illegal public deposit collection, but the company's operations remain normal [3] - Hengshi Technology's control is set to change as it enters a strategic cooperation agreement with New Base Information Technology Group [4] Group 3 - Zhejiang Mining plans to acquire 100% of Alaigyr Company, which holds core assets in lead-silver mines [5][6] - Guizhou Tire intends to invest in a project in Morocco to produce 6 million semi-steel radial tires annually, with a total investment of 299 million USD [7] - Dongfang Zircon plans to invest in a project to produce 10,000 tons of high-purity composite zircon oxide for new energy batteries [8] Group 4 - Xingsheng Group has received a project designation notice from a North American electric vehicle manufacturer, with a total sales amount of approximately 7.8 billion yuan [18] - Jin Di Co. plans to acquire a 3.36% stake in Baoshilai New Materials Technology for 21.6 million yuan [10] - Huayi Technology has signed a strategic cooperation agreement with Fujian Fuyou University to enhance research and development in alloy materials [6] Group 5 - Juxing Technology expects a net profit increase of 5% to 20% in 2025 [23] - Huayou Cobalt anticipates a net profit increase of 40.8% to 55.24% in 2025 [24] - Chifeng Gold expects a net profit increase of approximately 70% to 81% in 2025 [25]

登云股份（002715）1月5日晚间公告，公司于1月4日收到公司实际控制人杨涛先生家属提供的京公朝捕 通字[2025]51878号《逮捕通知书》获悉，经北京市朝阳区人民检察院批准，北京市公安局朝阳分局于 2025年12月25日对涉嫌非法吸收公众存款罪的杨涛执行逮捕。 杨涛控制下的企业，从2018年开始入局登云股份，并在2019年正式入主这家上市公司。 2019年2月20日晚间，登云股份披露公告称，公司控股股东及一致行动人张弢等九股东与益科正润签署 了《股份转让协议》，拟将其所持有的公司6.78%股权协议转让给益科正润，转让价格为17.75元/股。 据此计算，本次股权转让的交易总金额为1.11亿元。本次股权转让完成后，益科正润持有登云股份 21.63%的股份，公司控股股东变更为益科正润，公司实际控制人变更为益科正润的实际控制人杨涛。 登云股份披露的信息显示，杨涛曾用名杨鑫涛，1975年生，中国国籍，无境外永久居住权，主要职业及 职务为：河南汇源投资有限公司董事长；北京聚丰科投资有限责任公司董事长；益科正润投资集团有限 公司董事；聚益科资产管理集团有限公司董事等。 公开信息显示，杨涛是"益科系"创始人杨根水的儿子 ...

智通财经APP讯，登云股份(002715.SZ)公告，公司于2026年1月4日收到公司实际控制人杨涛先生家属提 供的京公朝捕通字[2025]51878号《逮捕通知书》获悉，经北京市朝阳区人民检察院批准，北京市公安 局朝阳分局于2025年12月25日对涉嫌非法吸收公众存款罪的杨涛执行逮捕。 ...

登云股份（002715）(002715.SZ)公告，公司于2026年1月4日收到公司实际控制人杨涛先生家属提供的 京公朝捕通字[2025]51878号《逮捕通知书》获悉，经北京市朝阳区人民检察院批准，北京市公安局朝 阳分局于2025年12月25日对涉嫌非法吸收公众存款罪的杨涛执行逮捕。 ...

Group 1 - The actual controller of Dengyun Co., Yang Tao, has been arrested for allegedly illegally absorbing public deposits, as confirmed by a notice from the Beijing Chaoyang District People's Procuratorate [3][5] - Dengyun Co. stated that its business operations remain normal and that Yang Tao does not hold any director or senior management positions, indicating that the arrest will not significantly impact the company's governance or daily operations [5] - Yang Tao became the actual controller of Dengyun Co. in 2019 after a share transfer agreement that changed the controlling shareholder to Yike Zhengrun [5] Group 2 - On January 5, Dengyun Co. announced that its controlling shareholder, Yike Ruihai, has had part of its shares, totaling 14,501,182.56 shares, judicially frozen due to ongoing litigation [7][8] - As of January 5, Yike Ruihai holds 31,799,134 shares of Dengyun Co., representing 23.04% of the total share capital, with 45.60% of its holdings being frozen [8] - Dengyun Co.'s Vice President, Sun Shaobo, has resigned for personal reasons and will no longer hold any position within the company [9]

Group 1 - The actual controller of Dengyun Co., Yang Tao, has been arrested for allegedly illegally absorbing public deposits, marking another instance of an A-share company controller facing legal issues [2][3][4] - Dengyun Co. announced that its business operations remain normal despite Yang Tao's arrest, as he does not hold any director or senior management positions within the company [6] - Yang Tao became the actual controller of Dengyun Co. in February 2019 after a share transfer agreement that changed the controlling shareholder to Yike Zhengrun [7] Group 2 - On January 5, Dengyun Co. reported that its controlling shareholder, Yike Ruihai, has had part of its shares, totaling 14.5 million shares, judicially frozen due to ongoing litigation [10] - As of January 5, Yike Ruihai holds 31.8 million shares of Dengyun Co., representing 23.04% of the total share capital, with a market value of approximately 605 million yuan [11][12] - The company’s main business involves the research, production, and sales of automotive engine intake and exhaust valves, serving well-known manufacturers such as Cummins and Caterpillar [12]

Group 1 - Postal Savings Bank announced a cash dividend distribution of 14.772 billion yuan for the first half of 2025, with a dividend of 1.23 yuan per 10 shares [1] - Xinke Mobile plans to reduce its shareholding by up to 1%, amounting to a maximum of 34.1875 million shares, due to funding needs [1] - Defu Technology signed a cooperation letter with a leading domestic CCL company to supply high-end electronic circuit copper foil products, which is expected to positively impact the company's performance in 2026 [1] Group 2 - Sanxia New Materials intends to acquire 40% equity of Lingang New Materials for a transaction amount of 0 yuan, which constitutes a related party transaction [2] - Fulim Precision plans to invest a total of 87 billion yuan in projects for the production of high-end lithium iron phosphate for energy storage, with the main project estimated at 60 billion yuan [3] - Heng Rui Pharmaceutical received approval for clinical trials of HRS9531 injection in combination with HRS-5817 injection for treating obesity in adults [3] Group 3 - Quartz Co. was fined 2.7 million yuan for commercial secret infringement, with the company being the victim in this case [5] - ST Renfu received approval for clinical trials of HW221043 tablets for late-stage solid tumors, with no similar drugs approved domestically or internationally [6] - Tianchen Medical signed a strategic cooperation agreement with Inspur Digital Technology to promote innovation in medical robotics and smart manufacturing [6] Group 4 - Xusheng Group received a notification from a North American electric vehicle manufacturer for a project with an estimated total sales amount of approximately 7.8 billion yuan over its lifecycle [6] - Deyun Co. announced that its actual controller was arrested for illegal public deposit collection, but this does not significantly impact the company's operations [7] - Shengyang Technology's subsidiary is advancing a project with a global satellite operator in South America, focusing on software licensing and product delivery [7] Group 5 - Hefei China announced a 1% reduction in shares by its controlling shareholder, who terminated the reduction plan early to express confidence in the company's future [8] - Weigao Blood Purification plans to acquire 100% equity of Weigao Purui for 8.511 billion yuan, which will expand its business into drug delivery systems [10]

格隆汇1月5日｜登云股份(002715)公告，公司于2026年1月4日收到杨涛家属提供的京公朝捕通字 [2025]51878号《逮捕通知书》，北京市朝阳区人民检察院批准，北京市公安局朝阳分局已于2025年12 月25日对涉嫌非法吸收公众存款罪的实际控制人杨涛执行逮捕。杨涛未在公司担任董事、高级管理人员 职务，目前公司经营情况正常，上述事项不构成对公司治理及日常生产经营的重大影响。 ...

Group 1 - The actual controller of Dengyun Co., Yang Tao, was arrested on December 25, 2025, for allegedly illegally absorbing public deposits, as confirmed by the arrest notice from the Beijing Chaoyang District People's Procuratorate [1] - Dengyun Co. stated that its business operations remain normal despite Yang Tao's arrest, and he does not hold any director or senior management positions within the company [1] - The company emphasizes that the incident will not have a significant impact on its governance and daily operations [1] Group 2 - Dengyun Co. was established on May 10, 1971, with a registered capital of 138 million RMB, and its legal representative is Yang Haikun [4] - The main business of Dengyun Co. involves the research, production, and sales of automotive engine intake and exhaust valves [4] - The company's revenue for the years 2022, 2023, and 2024 was reported as 507 million RMB, 544 million RMB, and 511 million RMB, respectively, with net profits of -132 million RMB, 23.78 million RMB, and 5.13 million RMB [5]

Group 1 - The actual controller of Dengyun Co., Yang Tao, was arrested for allegedly illegally absorbing public deposits, as confirmed by the arrest notice from the Beijing Chaoyang District People's Procuratorate [1] - Dengyun Co. stated that its business operations remain normal and that Yang Tao does not hold any director or senior management positions, indicating that the incident will not significantly impact the company's governance or daily operations [1] Group 2 - Dengyun Co. was established on May 10, 1971, with a registered capital of 138 million RMB, and its main business involves the research, development, production, and sales of automotive engine intake and exhaust valves [4] - The company's revenue for the years 2022, 2023, and 2024 was reported as 507 million RMB, 544 million RMB, and 511 million RMB, respectively, while the net profit attributable to shareholders was -132 million RMB, 23.78 million RMB, and 5.13 million RMB for the same years [4]